US · 21 CFR
21 CFR 211.89
Rejected components, drug product containers, and closures.
21 CFR Part 211 › Subpart E—Control of Components and Drug Product Containers and Closures
Section text
Rejected components, drug product containers, and closures shall be identified and controlled under a quarantine system designed to prevent their use in manufacturing or processing operations for which they are unsuitable.
Source: U.S. Office of the Federal Register / GPO — eCFR · U.S. federal government work — public domain (17 U.S.C. §105). eCFR is an editorial compilation, not an official legal edition of the CFR. · retrieved 2026-11-15